《经导管主动脉瓣置换术中国专家共识(2020更新版)》解读

Interpretation of the 2020 updated version of Chinese Expert Consensus on Transcatheter Aortic Valve Replacement

经导管主动脉瓣置换术(transcatheter aortic valve replacement,TAVR)是治疗症状性重度主动脉瓣狭窄的重要治疗方式。《经导管主动脉瓣置换术中国专家共识(2020更新版)》在中国进行TAVR探索的进程中应运而生,对于正在从起步阶段进入快速发展阶段的中国TAVR领域具有跨时代的指导意义,同时进一步促进了中国TAVR领域的规范健康发展。在2015版《经导管主动脉瓣置换术中国专家共识》的基础上,《经导管主动脉瓣置换术中国专家共识(2020更新版)》将外科手术风险低危的主动脉瓣狭窄归入适应证,对TAVR术中球囊扩张和瓣膜置入的操作规范提出了更详细的建议,增加了TAVR术后抗栓方案和对冠状动脉粥样硬化性心脏病、肾功能不全及急诊TAVR的处理等重要意见。该文将以上述更新为主对更新版共识进行详细解读。

Transcatheter aortic valve replacement(TAVR)is an important treatment for patients with symptomatic severe aortic stenosis.The 2020 updated version of Chinese Expert Consensus on Transcatheter Aortic Valve Replacement was born in the process of Chinese exploration for TAVR.It is of epochal guiding significance for TAVR in China,which has entered a stage of rapid development from the initial stage.Moreover,it further promotes the standardized and healthy development of TAVR in China.The 2020 updated version of Chinese Expert Consensus on Transcatheter Aortic Valve Replacement,based on its 2015 version,has included aortic valve stenosis with a low risk of surgical operation as an indication,made more detailed recommendations on the operating specifications of balloon dilation and valve placement during TAVR,added the antithrombotic program after TAVR,and important opinions on the treatment of coronary atherosclerotic heart disease,renal insufficiency,and emergency TAVR.In this article,we will focus on all these updates to interpret the updated consensus in detail.